Datasets:
jarrydmartinx
/
support2

Dataset card Data Studio Files
xet
Community
age
float64
18
102
sex
stringclasses
2 values
hospdead
int64
0
1
slos
int64
3
343
dzgroup
stringclasses
8 values
dzclass
stringclasses
4 values
num.co
int64
0
9
edu
float64
0
31
⌀
income
stringclasses
4 values
scoma
float64
0
100
⌀
charges
float64
1.17k
1.44M
⌀
totcst
float64
0
633k
⌀
totmcst
float64
-102.72
711k
⌀
avtisst
float64
1
83
⌀
race
stringclasses
5 values
sps
float64
0.2
99.2
⌀
aps
float64
0
143
⌀
surv2m
float64
0
0.97
⌀
surv6m
float64
0
0.95
⌀
hday
int64
1
148
diabetes
int64
0
1
dementia
int64
0
1
ca
stringclasses
3 values
prg2m
float64
0
1
⌀
prg6m
float64
0
1
⌀
dnr
stringclasses
3 values
dnrday
float64
-88
285
⌀
meanbp
float64
0
195
⌀
wblc
float64
0
200
⌀
hrt
float64
0
300
⌀
resp
float64
0
90
⌀
temp
float64
31.7
41.7
⌀
pafi
float64
12
890
⌀
alb
float64
0.4
29
⌀
bili
float64
0.1
63
⌀
crea
float64
0.1
21.5
⌀
sod
float64
110
181
⌀
ph
float64
6.83
7.77
⌀
glucose
float64
0
1.09k
⌀
bun
float64
1
300
⌀
urine
float64
0
9k
⌀
adlp
float64
0
7
⌀
adls
float64
0
7
⌀
sfdm2
stringclasses
5 values
adlsc
float64
0
7.07
event_times
int64
3
2.03k
event_indicators
int64
0
1
35.52597
female
1
9
ARF/MOSF w/Sepsis
ARF/MOSF
3
14
under $11k
41
190,585
50,592.1562
53,178.5312
52
white
28.398438
44
0.584961
0.475952
12
0
0
yes
0.2
0.2
dnr after sadm
6
135
5
120
20
36.5
153.3125
null
null
0.799927
149
7.449219
399
26
1,770
null
0
<2 mo. follow-up
0
9
1
80.46295
male
0
5
CHF
COPD/CHF/Cirrhosis
2
16
>$50k
0
13,833
6,499.4727
7,339.70703
11
white
15.699219
9
0.861938
0.771973
1
0
0
no
0.93
0.75
no dnr
5
82
5.5
80
20
36.5
null
3.199707
0.799927
1.199951
142
null
91
26
2,500
1
1
no(M2 and SIP pres)
1
1,025
0
44.02499
male
0
6
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
under $11k
55
35,099
14,571.9219
56,632.7188
38
white
29.597656
39
0.608887
0.50293
1
0
0
no
0.2
0.1
no dnr
6
75
11.199219
100
10
37.5
328.5625
2
35
1.199951
136
7.429688
106
19
3,520
null
6
<2 mo. follow-up
6
8
1
35.26599
male
0
11
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
$11-$25k
0
48,956
23,854.9062
24,607.375
15
white
15
19
0.94397
0.922974
1
0
0
no
0.8
0.8
no dnr
11
66
13.099609
82
16
38.39844
245
2.799805
0.099991
0.799927
148
7.319336
110
4
2,870
6
6
SIP>=30
6
1,023
0
37.25098
male
1
3
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
$11-$25k
55
83,192
13,650.0703
15,727.7344
40
white
54.796875
84
0.008999
0.001
21
0
0
no
0
0
dnr after sadm
2
42
12
85
24
38.79688
70
3.699707
37
5.599609
142
7.579102
110
49
0
null
null
<2 mo. follow-up
3.012207
3
1
62.133
male
1
13
CHF
COPD/CHF/Cirrhosis
4
12
>$50k
0
153,171
40,508.2812
48,524.2812
30
white
31
40
0.628906
0.444946
13
0
0
no
0.7
0.7
no dnr
13
47
11.5
80
20
36.79688
null
null
null
3
132
null
null
77
3,885
0
null
<2 mo. follow-up
0.494751
13
1
32.64099
female
1
35
MOSF w/Malig
ARF/MOSF
2
12
$11-$25k
0
358,494
126,852.438
118,579.5
25.25
white
27.097656
54
0.589966
0.481995
13
0
0
yes
0.85
0.5
dnr after sadm
34
107
0.099991
78
20
38
null
null
2
2.199707
137
null
307
70
3,475
0
0
<2 mo. follow-up
0
35
1
76.44098
male
0
9
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
$25-$50k
0
23,486
11,454.5703
12,023.6094
9.5
white
25.5
37
0.612915
0.507935
1
1
0
metastatic
0.9
0.8
no dnr
9
78
21.296875
84
16
36
250
3
0.399963
5.5
131
7.40918
189
69
2,560
0
0
no(M2 and SIP pres)
0
220
1
77.59094
male
1
19
ARF/MOSF w/Sepsis
ARF/MOSF
3
8
under $11k
37
355,655
84,230.5625
111,434.375
56
white
30
62
0.337952
0.221985
28
0
0
no
0.1
0.1
dnr after sadm
3
57
18
115
32
38.5
224
null
1.799805
3.5
142
7.279297
137
73
1,035
null
null
<2 mo. follow-up
3.719238
19
1
51.09698
male
0
12
Lung Cancer
Cancer
2
16
null
0
37,350
17,216.1094
15,744.8359
26
white
27.097656
29
0.503906
0.18399
1
0
0
metastatic
1
1
no dnr
12
65
16.597656
135
36
37.5
200
null
null
0.899902
130
7.399414
126
9
2,547
null
0
null
0
112
1
95.70697
female
1
3
ARF/MOSF w/Sepsis
ARF/MOSF
2
14
>$50k
100
16,032
6,691.8477
65,455.625
5
white
27.5
87
0.115997
0.050995
1
0
1
no
null
null
dnr before sadm
-1
65
35.09375
115
40
36
374
null
null
1.699951
137
7.299805
395
44
20
null
null
<2 mo. follow-up
6.928711
3
1
78.18799
female
0
5
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
9
18,497
9,117.4766
8,865.25781
9
white
16.296875
7
0.844971
0.791992
1
0
1
no
0.9
0.9
no dnr
5
98
10
98
20
37
348.5625
null
null
1.099854
139
7.589844
114
8
1,650
null
null
null
4.931641
1,018
0
61.142
male
0
29
ARF/MOSF w/Sepsis
ARF/MOSF
2
22
$25-$50k
0
365,437
68,879
94,911.625
24.25
black
32
67
0.579956
0.469971
26
1
0
no
0.8
0.6
no dnr
29
118
10.199219
65
36
35.39844
167.5
3.399902
2.799805
6.299805
136
7.469727
281
101
0
null
2
<2 mo. follow-up
2
56
1
84.99695
male
0
6
Coma
Coma
2
null
null
100
19,473
8,654.4922
8,656.26562
9
white
16
23
0.156982
0.103989
1
0
0
yes
0.05
0
dnr after sadm
2
119
14
82
20
38.39844
487.5
null
null
1.399902
133
7.429688
170
20
850
null
null
<2 mo. follow-up
3.388672
9
1
84.37195
female
0
13
ARF/MOSF w/Sepsis
ARF/MOSF
0
10
null
37
64,321
23,580.1406
31,104.3281
24.5
white
26.199219
40
0.485962
0.367981
3
0
0
no
0.1
0.05
dnr after sadm
3
58
13.699219
145
12
39.39844
371.375
2.5
0.5
0.799927
129
7.319336
157
30
3,125
null
3
<2 mo. follow-up
3
18
1
77.99298
male
1
4
CHF
COPD/CHF/Cirrhosis
0
21
$25-$50k
26
90,070
10,376.7812
13,071.2656
37
black
30.296875
67
0.383972
0.188995
27
0
0
no
null
null
dnr after sadm
3
53
21.199219
65
28
37.59375
246.65625
null
0.799927
2.599609
129
7.289062
108
73
162
null
null
<2 mo. follow-up
2.666504
4
1
79.97797
male
1
11
ARF/MOSF w/Sepsis
ARF/MOSF
3
10
$11-$25k
55
121,331
38,597.4688
44,131.0938
42
white
31.5
49
0.243988
0.140991
5
0
0
no
0.1
0.05
dnr after sadm
11
58
9.298828
70
12
38.19531
127.5
null
2.199707
4.599609
129
7.40918
97
87
2,631
null
6
<2 mo. follow-up
6
11
1
79.06396
male
1
11
ARF/MOSF w/Sepsis
ARF/MOSF
0
16
$25-$50k
37
107,076
39,846.7812
48,046.5625
43.5
white
34
80
0.312988
0.199982
2
0
0
no
0.2
0.2
dnr after sadm
11
58
26.296875
165
22
38
73
2.199707
0.899902
1.799805
145
7.449219
189
38
1,559
null
0
<2 mo. follow-up
0
11
1
45.043
male
1
3
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
under $11k
55
30,354
12,436.8125
16,955.6875
29
white
85.1875
104
0
0
1
0
0
no
0.1
0.05
dnr after sadm
2
5
14.5
0
5
38.79688
120
3.299805
1.799805
4.399414
124
7.719727
100
92
275
null
null
<2 mo. follow-up
1.614258
3
1
50.155
male
0
27
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
>$50k
0
372,270
82,504.6875
95,984.4375
28.5
white
26.597656
40
0.756958
0.679932
20
0
0
no
0.8
0.7
no dnr
27
113
13.599609
110
6
38.29688
267.5
2.799805
4.199219
2.699707
137
7.419922
330
111
3,826
null
0
adl>=4 (>=5 if sur)
0
489
1
56.211
female
0
24
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
$11-$25k
0
135,949
51,641.1562
56,310.7812
35
white
24.898438
38
0.793945
0.726929
4
0
0
no
0.7
0.7
no dnr
24
65
11.5
45
14
38.5
270
2.899902
1.099854
3.699707
139
7.459961
89
32
1,965
null
5
adl>=4 (>=5 if sur)
5
1,011
0
51.18698
female
0
6
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
0
56,973
10,217.1094
14,171.0625
12
white
31.898438
27
0.532959
0.417969
6
0
0
metastatic
0
0
dnr before sadm
-3
75
13.798828
126
16
36.69531
114.28125
null
null
1.599854
132
7.389648
164
13
3,150
null
null
<2 mo. follow-up
2.859863
17
1
47.95099
male
0
10
MOSF w/Malig
ARF/MOSF
3
18
$11-$25k
0
53,439
16,939.0469
18,911.2344
23.5
hispanic
24.199219
51
0.615967
0.510986
3
0
0
metastatic
0.15
0.05
dnr after sadm
4
98
12.5
110
36
39.39844
419
1.799805
null
1.599854
134
7.369141
157
25
1,450
null
0
adl>=4 (>=5 if sur)
0
77
1
100.24597
male
1
3
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
100
51,328
17,097.4062
21,092.9688
50
white
69.5
111
0
0
1
0
0
no
0
0
dnr after sadm
3
22
15.599609
130
26
36.5
56
2.299805
12.898438
2.299805
145
7.359375
49
18
0
null
null
<2 mo. follow-up
4.179688
3
1
75.95294
male
1
4
Coma
Coma
1
17
$11-$25k
100
13,525
6,125.9453
7,656.14844
7
white
24.898438
37
0.051994
0.026997
1
0
0
yes
null
null
dnr after sadm
2
100
100
76
28
40.69531
211
null
null
1.799805
135
7.40918
179
32
1,600
null
null
<2 mo. follow-up
3.084961
4
1
36.39398
male
1
64
ARF/MOSF w/Sepsis
ARF/MOSF
4
12
under $11k
0
492,853
180,981.875
200,351.25
28.25
black
22.898438
39
0.86499
0.817993
8
0
0
no
null
null
no dnr
64
65
9.298828
115
26
36.79688
null
null
null
1.5
150
null
153
38
1,467
null
5
null
5
64
1
76.21399
female
0
7
COPD
COPD/CHF/Cirrhosis
2
14
under $11k
0
30,490
8,519.5
8,446.625
9
white
30.597656
47
0.577881
0.383972
2
0
0
no
null
null
no dnr
7
107
11.199219
110
12
36.39844
65
null
0.199982
1.199951
143
7.299805
132
25
1,600
2
3
no(M2 and SIP pres)
3
1,003
0
87.05798
female
0
40
ARF/MOSF w/Sepsis
ARF/MOSF
1
16
null
26
202,508
71,926.125
76,031
26.5
white
27.796875
43
0.233978
0.133972
15
0
0
metastatic
0.85
0.85
no dnr
40
72
18.597656
115
26
37.89844
206.09375
null
null
2
131
7.5
156
55
2,990
null
5
adl>=4 (>=5 if sur)
5
956
1
80.10095
female
0
37
ARF/MOSF w/Sepsis
ARF/MOSF
1
16
$25-$50k
44
299,289
109,288.875
135,325.125
43
white
29.199219
41
0.277954
0.168976
5
0
0
yes
0.7
0.7
no dnr
37
132
12.798828
115
28
36.79688
117.14062
2.5
0.599976
0.699951
136
7.399414
152
19
4,355
null
0
<2 mo. follow-up
0
47
1
62.724
female
1
15
Coma
Coma
1
18
$11-$25k
61
109,193
45,729.5938
171,166.25
35.666657
white
22
21
0.487976
0.415955
1
0
0
no
0
0
dnr after sadm
13
130
10.5
65
15
38.39844
146
3.699707
0.799927
0.599976
133
7.489258
150
5
2,495
null
null
<2 mo. follow-up
2.427246
15
1
81.50897
male
0
7
CHF
COPD/CHF/Cirrhosis
5
12
under $11k
0
13,004
7,194.4648
8,583.49219
9
white
19.699219
31
0.81189
0.694946
1
1
1
no
0.8
0.4
no dnr
7
111
6.199219
80
26
36
null
null
null
1.899902
140
null
null
33
950
null
4
adl>=4 (>=5 if sur)
4
1,000
0
32.08499
male
0
34
CHF
COPD/CHF/Cirrhosis
3
12
null
0
162,263
71,892.875
85,921.5625
29.25
hispanic
20.796875
31
0.925903
0.875
1
0
0
no
0.5
0.25
no dnr
34
53
5.599609
105
16
36.5
null
3.899902
1.099854
1.299805
134
null
103
27
4,955
2
5
no(M2 and SIP pres)
5
877
1
71.85498
male
1
7
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
under $11k
26
95,439
26,086.2969
33,033.1875
42
asian
42.796875
65
0.135986
0.062988
5
0
0
no
0.1
0.05
dnr after sadm
7
55
11.599609
105
32
36.5
134
2.399902
1.599854
4.299805
125
7.419922
null
71
2,795
null
0
<2 mo. follow-up
0
7
1
90.20697
female
0
4
ARF/MOSF w/Sepsis
ARF/MOSF
1
9
$11-$25k
0
12,549
5,989.2891
5,923.54688
11
white
26.296875
48
0.657959
0.559937
1
0
0
no
null
null
no dnr
4
75
8.298828
70
22
35.89844
134.6875
null
null
2.699707
137
7.25
390
38
600
0
null
null
0.494751
476
1
67.92896
female
0
15
CHF
COPD/CHF/Cirrhosis
0
8
under $11k
0
82,258
36,620.5312
43,184.7812
26
hispanic
19.796875
23
0.85498
0.760986
1
0
0
no
0.5
0.5
dnr after sadm
5
57
7.099609
55
22
36.29688
null
null
null
0.899902
134
null
140
15
1,890
1
null
SIP>=30
1.166748
129
1
35.76498
female
0
14
ARF/MOSF w/Sepsis
ARF/MOSF
4
13
$25-$50k
0
94,457
38,957.1562
45,480.5938
27.333328
white
28.597656
30
0.837891
0.782959
1
0
0
no
0.6
0.7
no dnr
14
130
16
120
20
39
114.28125
2.599609
0.5
0.599976
136
7.40918
104
11
3,540
null
5
no(M2 and SIP pres)
5
996
0
73.75494
female
1
28
Coma
Coma
1
12
under $11k
89
334,890
101,755.062
117,419.125
38.25
hispanic
23.898438
62
0.047997
0.023998
18
0
0
yes
0.09
0.000729
dnr after sadm
12
125
0.049995
125
40
38.89844
260
2.199707
1.899902
0.799927
152
7.509766
314
17
4,755
null
5
<2 mo. follow-up
5
28
1
54.004
female
0
58
ARF/MOSF w/Sepsis
ARF/MOSF
4
12
$25-$50k
37
748,973
null
null
46
white
48.5
84
0.049995
0.015999
17
1
0
no
0.1
0.1
no dnr
58
45
0.199982
105
32
36.89844
202
3.299805
4.5
3.599609
142
7.359375
163
95
525
null
1
adl>=4 (>=5 if sur)
1
991
0
52.51199
female
0
15
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
>$50k
0
69,096
19,972.7031
18,123.1094
10
white
21
27
0.814941
0.75293
5
0
0
yes
0.99
0.98
no dnr
15
88
13.398438
142
20
38.19531
256.625
1.399902
null
0.699951
136
7.359375
113
5
3,400
0
3
no(M2 and SIP pres)
3
990
0
38.168
female
0
23
ARF/MOSF w/Sepsis
ARF/MOSF
1
20
$25-$50k
44
151,909
61,569.8125
71,126.6875
31.666656
hispanic
30.898438
63
0.656982
0.55896
1
0
0
no
0.5
0.5
no dnr
23
102
27.199219
140
26
38.09375
146.65625
2
0.799927
1.899902
151
7.259766
131
21
2,665
null
null
SIP>=30
2.968262
990
0
49.02399
female
1
5
ARF/MOSF w/Sepsis
ARF/MOSF
4
12
$25-$50k
0
64,403
22,841.6094
28,431.3281
55
white
49
77
0.273987
0.165985
2
0
0
no
0.2
0.1
dnr after sadm
5
55
26.699219
105
10
35.5
186
3.299805
48.5
3
139
7.279297
164
83
645
null
0
<2 mo. follow-up
0
5
1
47.96198
male
0
7
COPD
COPD/CHF/Cirrhosis
1
14
under $11k
0
39,258
16,408.9688
17,686.3594
20.5
white
29.699219
38
0.837891
0.734985
1
0
0
no
0.95
0.98
no dnr
7
112
19.296875
135
40
37.89844
134.03125
3.399902
0.799927
0.799927
136
7.40918
null
25
3,950
1
null
null
1.166748
988
0
22.91299
male
0
25
ARF/MOSF w/Sepsis
ARF/MOSF
0
13
null
0
59,999
30,400.7031
29,596.125
18
black
18.898438
29
0.938965
0.916992
1
0
0
no
0.9
0.98
no dnr
25
65
11.099609
114
24
37.59375
null
2.599609
0.899902
1.099854
141
null
156
35
1,330
null
7
adl>=4 (>=5 if sur)
7
987
0
68.53894
male
0
29
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
26
246,417
58,176.3125
175,344.5
25.25
black
18.699219
8
0.804932
0.740967
1
1
0
no
null
null
no dnr
29
87
8.599609
115
6
38.69531
270
null
null
0.799927
149
7.449219
166
13
2,675
null
null
null
2.462402
985
0
94.80096
female
0
5
Lung Cancer
Cancer
1
null
null
44
11,088
5,479.2695
5,763.35938
16
white
21.597656
36
0.284973
0.044998
1
0
0
metastatic
0.25
0.05
no dnr
5
65
15.5
78
28
35.39844
null
null
null
0.799927
133
null
108
28
700
null
null
<2 mo. follow-up
4.578125
57
1
47.88498
female
0
19
ARF/MOSF w/Sepsis
ARF/MOSF
3
null
null
26
165,774
35,300.3125
36,197.8125
33
black
27.699219
49
0.60791
0.501953
8
1
0
yes
null
null
no dnr
19
52
9.599609
125
28
38.09375
175
2.199707
null
1.099854
144
7.419922
290
26
2,761
null
null
null
3.193359
887
1
52.98599
male
0
8
CHF
COPD/CHF/Cirrhosis
2
12
null
0
24,044
11,732.8672
12,113.2734
16
white
19.699219
23
0.894897
0.823975
1
0
0
no
0.9
0.8
no dnr
8
68
7.699219
115
28
39.09375
null
null
0.699951
1.299805
136
null
null
12
3,960
0
1
no(M2 and SIP pres)
1
494
1
41.26199
male
0
40
ARF/MOSF w/Sepsis
ARF/MOSF
1
16
>$50k
0
346,799
97,818.8125
128,462.438
31
white
29.699219
70
0.763916
0.688965
6
0
0
no
0.8
0.8
no dnr
40
63
13.199219
170
40
38.5
192
2.5
6.399414
1
141
7.5
252
30
2,010
null
1
no(M2 and SIP pres)
1
982
0
60.96899
male
0
14
ARF/MOSF w/Sepsis
ARF/MOSF
3
10
$11-$25k
9
156,906
81,478.125
75,389.9375
32.666657
white
32.296875
36
0.643921
0.542969
1
0
0
no
0.6
0.4
no dnr
14
47
14.699219
105
30
37.69531
158.3125
null
1
1.299805
141
7.539062
97
27
4,730
null
5
no(M2 and SIP pres)
5
982
0
71.84698
male
0
30
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
37
210,555
78,092.875
88,523.125
37.25
white
69.890625
78
0
0
4
1
0
no
0.2
0.2
no dnr
30
0
6.299805
0
12
38.59375
345
2.5
0.699951
4.899414
133
7.399414
476
84
1,941
null
null
null
2.04541
980
0
84.31799
male
0
51
ARF/MOSF w/Sepsis
ARF/MOSF
1
18
>$50k
0
462,018
154,909.25
152,019.375
32.75
asian
20
34
0.797974
0.730957
1
0
0
no
0.6
0.5
dnr after sadm
45
63
9.699219
55
18
36.09375
191.40625
2.299805
null
1.199951
137
7.259766
null
29
1,870
null
null
null
2.802246
303
1
38.21799
female
1
6
Coma
Coma
3
14
>$50k
26
97,521
18,105.5781
19,183.1562
34
white
44.195313
75
0.093994
0.056
21
0
0
yes
0.75
0.7
dnr after sadm
4
118
15.898438
126
44
37.79688
160
2.199707
26.398438
1.899902
127
7.40918
null
24
3,275
null
5
<2 mo. follow-up
5
6
1
79.15698
female
1
4
Coma
Coma
2
15
$25-$50k
100
16,231
7,312.875
8,866.6875
27
white
45.5
64
0
0
1
0
0
yes
0.02
0.02
dnr after sadm
3
32
19.097656
195
10
35.79688
266.625
null
null
2.099609
145
7.569336
273
19
1,628
null
null
<2 mo. follow-up
3.667969
4
1
33.59097
male
0
10
ARF/MOSF w/Sepsis
ARF/MOSF
2
16
$25-$50k
0
81,881
19,257.6094
25,287.2656
12
hispanic
36.796875
40
0.630981
0.528931
17
0
0
no
0.9
0.8
no dnr
10
81
2.099609
95
16
37.59375
40
null
0.699951
2.299805
138
7.549805
120
38
2,096
2
null
no(M2 and SIP pres)
1.838867
979
0
73.61798
male
1
21
MOSF w/Malig
ARF/MOSF
1
16
>$50k
41
86,043
39,136.6875
44,971.0312
22.666656
white
19.199219
29
0.557983
0.445984
1
0
0
metastatic
0.5
0
dnr after sadm
5
62
5.599609
64
24
36
247.59375
2.099609
0.699951
0.799927
134
7.509766
215
15
2,410
null
5
<2 mo. follow-up
5
21
1
98.08899
female
1
4
Coma
Coma
1
16
under $11k
100
16,613
7,248.9062
9,300.8125
25
white
26.898438
16
0.006
0.002
1
0
1
no
0.15
0.15
dnr after sadm
1
82
10
135
24
36
190
null
null
0.399963
139
7.549805
155
5
2,525
null
null
<2 mo. follow-up
6.363281
4
1
65.09497
female
0
39
ARF/MOSF w/Sepsis
ARF/MOSF
0
18
null
26
358,169
103,605.875
127,812.75
39.25
white
20.597656
12
0.7229
0.636963
15
0
0
no
0.6
0.6
no dnr
39
103
11.099609
105
10
39.39844
240
3.799805
null
0.699951
136
7.539062
152
12
4,090
null
0
adl>=4 (>=5 if sur)
0
972
0
67.39197
female
0
26
ARF/MOSF w/Sepsis
ARF/MOSF
1
9
$11-$25k
41
213,912
49,587.5625
56,700.8438
21.25
black
29.597656
70
0.403992
0.283997
25
0
0
no
0.2
0.2
dnr after sadm
6
142
30
135
40
38.89844
576.625
2.399902
1
3
143
7.239258
286
62
5,785
null
0
<2 mo. follow-up
0
30
1
69.77698
male
0
11
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
null
37
88,609
21,318.4688
41,960.2812
44.5
white
21.597656
22
0.599976
0.491943
5
0
0
yes
null
null
no dnr
11
68
6
55
8
39.5
165.4375
null
null
1
136
7.459961
167
17
5,420
null
null
null
2.916016
972
0
77.20496
female
0
4
COPD
COPD/CHF/Cirrhosis
4
null
null
9
14,068
6,384.2812
6,269.42969
25
white
23.296875
46
0.718994
0.56189
1
0
0
no
0.9
0.8
no dnr
4
136
24.097656
150
24
36.39844
553
null
null
1
134
7.199219
89
27
790
null
null
null
3.659668
310
1
68.40796
female
0
8
COPD
COPD/CHF/Cirrhosis
6
null
null
0
19,252
10,880.3203
9,049.42969
11
white
16.296875
40
0.885986
0.809937
1
0
0
no
0.8
0.75
no dnr
8
75
4.299805
60
28
36.59375
339.125
null
0.599976
1.099854
141
7.369141
89
21
300
null
null
null
4.496094
971
0
74.25098
male
0
34
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
null
44
205,063
90,528.0625
119,766.75
39
white
41.796875
71
0.129974
0.058998
1
0
0
no
0.2
0.15
dnr after sadm
27
52
12
155
10
39.59375
280
2.5
10.099609
3.299805
153
7.459961
93
100
7,365
null
3
<2 mo. follow-up
3
37
1
35.92599
male
1
36
MOSF w/Malig
ARF/MOSF
2
12
$25-$50k
37
389,403
134,131.375
145,548.125
33
white
42.59375
79
0.034996
0.009998
23
0
0
yes
0.7
0.7
dnr after sadm
36
48
2
115
32
39.09375
246.9375
2
2.399902
4.199219
148
7.459961
null
101
210
null
0
<2 mo. follow-up
0
36
1
61.952
male
0
51
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
41
451,954
125,566.688
130,626.312
37
white
34.59375
57
0.292969
0.182983
25
0
0
no
0.2
0.2
no dnr
51
65
32.695313
115
37
39.09375
136.65625
null
null
5
143
7.469727
181
150
3,060
null
null
Coma or Intub
3.023438
271
1
75.87695
male
0
9
ARF/MOSF w/Sepsis
ARF/MOSF
1
19
>$50k
0
39,709
17,396.3906
20,330.3906
32
white
15.798828
25
0.872925
0.828979
1
0
0
no
0.6
0.3
no dnr
9
68
7.399414
95
8
37.69531
243.3125
null
null
1.299805
133
7.549805
null
25
4,468
null
null
no(M2 and SIP pres)
2.226563
969
0
50.034
female
1
5
MOSF w/Malig
ARF/MOSF
3
null
null
44
60,562
25,240.4688
31,265.9531
48
white
38.398438
54
0.133972
0.061996
1
0
0
yes
0.2
0.2
dnr after sadm
5
112
2.299805
125
26
39
140.8125
null
3.199707
2.299805
143
7.289062
166
36
6,295
null
null
<2 mo. follow-up
3.310547
5
1
66.90796
female
0
30
ARF/MOSF w/Sepsis
ARF/MOSF
2
15
null
9
137,219
57,231.9688
58,649.5
21.75
white
26.398438
24
0.565918
0.454956
3
0
0
metastatic
0.5
0.3
dnr after sadm
1
79
6.399414
110
24
36.39844
138.75
null
null
1
132
7.509766
168
10
2,620
null
5
<2 mo. follow-up
5
53
1
38.94299
female
1
16
Cirrhosis
COPD/CHF/Cirrhosis
5
12
under $11k
94
283,724
59,525.1562
61,740.7188
39
asian
46.695313
70
0.003
0
22
0
0
no
0.1
0.05
no dnr
16
118
null
115
34
36.5
178
null
50.09375
3.199707
151
7.579102
261
65
1,200
null
0
<2 mo. follow-up
0
16
1
32.07397
female
0
99
ARF/MOSF w/Sepsis
ARF/MOSF
5
null
null
41
793,804
343,271
403,864.75
48.5
hispanic
47.898438
90
0.241974
0.139984
1
1
0
no
0.7
0.7
no dnr
99
62
2.5
130
35
33.69531
323
2.399902
21.5
0.399963
148
7.399414
296
33
2,530
null
0
Coma or Intub
0
965
0
57.75198
female
0
4
CHF
COPD/CHF/Cirrhosis
1
11
under $11k
0
10,350
5,801.6016
7,100.69922
12
black
19.898438
37
0.881958
0.802979
1
0
0
no
null
null
no dnr
4
78
3.699707
65
28
36.29688
null
null
null
1.899902
139
null
97
66
1,350
1
1
SIP>=30
1
964
0
48.435
male
0
10
Colon Cancer
Cancer
1
null
null
0
18,298
9,905.8672
11,453.9375
18
white
14.099609
11
0.875977
0.719971
1
0
0
metastatic
0.7
0.6
no dnr
10
75
3.399902
70
20
36.39844
null
null
0.5
1
142
null
0
13
3,700
null
null
null
2.516113
507
1
56.50897
male
1
4
Coma
Coma
1
12
$11-$25k
55
25,303
9,744.8516
12,309.6562
33
white
17.5
33
0.612915
0.549927
1
0
0
yes
0.1
0
dnr after sadm
2
70
7.199219
65
37
38.19531
203.3125
2.899902
0.699951
1.299805
148
7.639648
126
30
3,155
null
null
<2 mo. follow-up
2.162598
4
1
48.47098
female
0
15
Lung Cancer
Cancer
1
17
under $11k
0
41,422
21,064.2656
117,872.188
15.333328
white
22.296875
19
0.634888
0.324951
1
0
0
metastatic
0.5
0.2
dnr after sadm
1
69
12.798828
112
24
36.19531
366.625
3.399902
0.199982
0.699951
136
7.469727
184
9
2,800
1
0
<2 mo. follow-up
0
22
1
23.24199
female
1
6
MOSF w/Malig
ARF/MOSF
2
16
under $11k
26
636,743
32,527.1719
31,102.0312
47
white
41.398438
53
0.077988
0.028999
85
0
0
yes
0
0
dnr after sadm
4
142
2.099609
65
14
38.39844
220
null
47.796875
3
141
7.389648
null
115
3,750
null
null
<2 mo. follow-up
2.65625
6
1
84.91394
male
0
16
CHF
COPD/CHF/Cirrhosis
5
16
null
0
42,792
22,130.0781
18,817.1719
15
white
18.898438
42
0.763916
0.625977
1
0
0
yes
0.5
0.25
no dnr
16
73
10.298828
74
22
36
204.75
null
null
1.5
137
7.469727
135
36
1,000
6
2
<2 mo. follow-up
2
33
1
57.28998
male
1
19
MOSF w/Malig
ARF/MOSF
2
14
>$50k
37
433,153
87,692.1875
104,910.438
37.333313
white
31.699219
47
0.199982
0.107986
46
0
0
yes
0.6
0.2
dnr after sadm
19
142
1.799805
130
36
36
297.125
null
2
0.799927
138
7.429688
186
34
4,203
null
0
<2 mo. follow-up
0
19
1
62.741
male
0
6
Cirrhosis
COPD/CHF/Cirrhosis
3
12
$11-$25k
0
17,289
10,762.1641
7,685.82812
11
hispanic
21.796875
45
0.743896
0.5979
1
0
0
no
0.9
0.8
no dnr
6
63
9.199219
64
12
36
null
2.199707
3.799805
0.899902
133
null
null
23
1,150
1
null
no(M2 and SIP pres)
1.166748
958
0
73.91595
female
0
19
Colon Cancer
Cancer
2
12
under $11k
0
37,120
19,875.8594
20,751.3281
11.333328
white
39
40
0.265991
0.037994
1
1
0
metastatic
0.3
0.1
no dnr
19
73
8.398438
118
30
38.39844
null
2
2.199707
0.699951
133
null
139
12
1,410
null
5
null
5
68
1
62.34598
male
1
5
ARF/MOSF w/Sepsis
ARF/MOSF
3
14
$25-$50k
26
54,050
23,091.9219
26,999.375
53
white
35.398438
54
0.475952
0.357971
1
0
0
no
0.6
0.6
no dnr
5
45
24.398438
75
27
39.79688
115
2
1.799805
1.199951
146
7.55957
145
56
2,540
null
0
<2 mo. follow-up
0
5
1
19.765
male
1
6
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
0
null
21,340.4375
97,894.9375
49
hispanic
35.09375
69
0.738892
0.657959
14
0
0
no
0.25
0.25
no dnr
6
45
18.796875
145
40
38.39844
402.8125
null
null
1.699951
135
7.369141
302
71
1,707
null
null
<2 mo. follow-up
2.135742
6
1
62.965
male
0
11
CHF
COPD/CHF/Cirrhosis
4
null
null
0
32,473
15,833.9297
15,820.7969
23.5
white
21
32
0.856934
0.763916
1
0
0
no
0.95
0.95
no dnr
11
115
8.5
75
20
36
null
null
0.199982
4.699219
139
null
104
50
1,175
null
null
null
3.517578
224
1
51.98398
male
0
10
Colon Cancer
Cancer
1
14
>$50k
0
30,678
13,849.9844
22,026.2812
18.5
white
16.796875
25
0.841919
0.651978
1
0
0
metastatic
0.9
0.09
no dnr
10
110
6.799805
105
10
38.39844
null
null
0.5
1.199951
140
null
169
null
740
0
0
null
0
656
1
78.62
female
0
9
Lung Cancer
Cancer
1
null
null
0
20,276
10,465.7656
10,816.3672
10.5
white
23.199219
39
0.522949
0.200989
1
0
0
metastatic
0.5
0.15
dnr after sadm
2
77
14
68
26
36.59375
323.75
null
null
1.299805
126
7.579102
100
20
600
1
null
null
1.166748
249
1
46.51898
female
1
9
Coma
Coma
1
null
null
100
79,492
27,622.1875
31,629.6406
33
black
33.796875
63
0.039993
0.019997
5
0
0
yes
null
null
dnr after sadm
9
122
19.097656
125
27
38.59375
205
null
null
5
127
7.30957
88
49
3,620
null
null
<2 mo. follow-up
3.140625
9
1
60.16699
male
1
10
MOSF w/Malig
ARF/MOSF
2
null
null
0
142,620
47,904.9375
56,030.5
57
white
40.898438
83
0.192993
0.10199
4
0
0
yes
0.5
0.25
dnr after sadm
9
48
0.399963
175
25
39.79688
301.375
1.799805
0.299988
0.299988
143
7.489258
154
9
2,310
null
2
<2 mo. follow-up
2
10
1
33.01297
female
1
4
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
$25-$50k
55
null
17,329.5156
18,879.5781
31
white
43.59375
81
0.161987
0.079987
38
0
0
no
null
null
dnr after sadm
4
117
4
120
54
38.5
490
2
28.5
2.599609
153
7.429688
256
115
2,500
null
null
<2 mo. follow-up
3.282227
4
1
53.71899
male
1
73
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
$25-$50k
9
651,870
204,370.375
204,853.625
30.5
white
33.796875
58
0.556885
0.44397
12
0
0
no
0.8
0.8
no dnr
73
45
13.898438
105
10
38.29688
402.5
null
null
5.399414
135
7.5
235
77
2
null
0
adl>=4 (>=5 if sur)
0
73
1
38.87698
male
0
60
ARF/MOSF w/Sepsis
ARF/MOSF
4
12
null
0
282,625
null
null
26.5
white
28.5
41
0.777954
0.705933
12
0
0
no
0.5
0.5
no dnr
60
112
12.298828
125
14
38.19531
155
null
0.899902
2.299805
142
7.509766
291
null
1,405
null
null
SIP>=30
3.08252
135
1
61.689
male
0
9
Colon Cancer
Cancer
1
null
null
0
16,468
9,625.2031
11,541.1641
21.5
white
12.398438
6
0.873901
0.716919
1
0
0
metastatic
null
null
no dnr
9
83
6.099609
80
22
38.29688
null
null
null
1
135
null
null
16
4,520
null
null
null
2.433106
153
1
69.125
female
0
8
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
under $11k
0
64,500
9,428.2891
25,010.8594
17
white
28.796875
34
0.645996
0.545898
7
0
0
no
0.98
0.95
no dnr
8
105
10.699219
120
28
36
134.6875
null
0.199982
0.799927
140
7.40918
null
null
540
0
2
no(M2 and SIP pres)
2
942
0
30.98399
female
0
19
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
37
175,051
75,655.5
77,528.0625
33.666657
white
31.597656
33
0.685913
0.593994
2
0
0
no
0.8
0.7
no dnr
19
115
6.099609
45
18
39.39844
43
null
2.099609
1.099854
144
7.449219
127
17
2,915
null
null
null
2.61377
941
0
62.75998
female
0
107
ARF/MOSF w/Sepsis
ARF/MOSF
4
16
null
44
985,215
271,083
259,698.125
38
white
33.796875
67
0.282959
0.173981
58
1
0
no
0.5
0.4
no dnr
107
112
6.099609
125
28
36.5
305
3.899902
6
2.899902
146
7.509766
349
59
0
null
0
null
0
941
0
62.28897
male
0
9
Colon Cancer
Cancer
1
12
under $11k
0
34,721
16,882.9219
19,613.2344
14.5
white
13.298828
13
0.86499
0.697998
1
0
0
metastatic
1
1
no dnr
9
63
null
62
20
38.39844
null
null
null
null
140
null
null
null
1,900
null
0
null
0
532
1
38.94299
male
0
12
ARF/MOSF w/Sepsis
ARF/MOSF
0
14
>$50k
0
147,307
34,028.1875
83,803.0625
32
white
30
62
0.744995
0.665894
17
0
0
no
0.9
0.9
no dnr
12
108
17.699219
115
28
36
304
1.899902
8.898438
1.199951
135
7.399414
330
22
1,360
null
5
adl>=4 (>=5 if sur)
5
75
1
53.314
female
0
71
ARF/MOSF w/Sepsis
ARF/MOSF
2
14
$25-$50k
37
517,087
149,585.125
140,814.375
41
asian
27.597656
39
0.594971
0.487
11
0
0
no
0.5
0.3
no dnr
71
60
22.898438
105
26
38.79688
257.5
2.899902
16
1.099854
137
7.479492
228
19
3,079
null
null
SIP>=30
3.120117
937
0
67.63898
male
0
9
Lung Cancer
Cancer
1
12
under $11k
0
21,057
11,093.6875
12,304.8438
13.5
white
15
9
0.73999
0.474976
1
0
0
metastatic
0.8
0.5
no dnr
9
103
9.5
76
22
36.39844
null
null
null
1.099854
135
null
null
12
2,595
0
0
SIP>=30
0
111
1
57.34698
male
0
16
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$11-$25k
0
139,549
58,391.7188
66,013.8125
34.666657
hispanic
30.5
54
0.731934
0.648926
1
1
0
no
0.6
0.6
no dnr
16
55
14.398438
120
36
37
140
2.699707
0.399963
1
136
7.399414
508
23
4,170
null
6
no(M2 and SIP pres)
6
937
0
40.14798
male
0
14
ARF/MOSF w/Sepsis
ARF/MOSF
4
16
$11-$25k
0
172,266
25,485.3281
36,137
17.333328
white
20.796875
33
0.879883
0.837891
6
0
0
no
null
null
no dnr
14
123
8.599609
115
24
37
222.5
3.099609
3.599609
0.899902
145
7.449219
154
61
3,550
0
0
no(M2 and SIP pres)
0
935
0
60.37
female
0
6
Colon Cancer
Cancer
1
12
>$50k
0
8,439
4,481.9922
4,730.26953
8
white
13.798828
11
0.861938
0.691895
1
0
0
metastatic
0.8
0.5
no dnr
6
73
10
80
20
38.5
null
null
0.399963
0.699951
136
null
99
6
3,550
0
0
no(M2 and SIP pres)
0
443
1
22.741
male
0
20
Coma
Coma
0
17
$25-$50k
0
150,904
61,721.625
70,461.8125
44
hispanic
35.695313
54
0.746948
0.699951
1
0
0
no
0.3
0.3
no dnr
20
115
17.699219
125
20
39
61
2.399902
3.099609
1.799805
145
7.549805
93
32
3,290
null
0
no(M2 and SIP pres)
0
934
0